Adalimumab Ameliorates Abdominal Aorta Cross Clamping Which Induced Liver Injury in Rats       
Yazarlar (9)
Erkan Cüre
Recep Tayyip Erdoğan Üniversitesi, Türkiye
Medine Cumhur Cüre
Recep Tayyip Erdoğan Üniversitesi, Türkiye
Levent Tümkaya
Recep Tayyip Erdoğan Üniversitesi, Türkiye
Yıldıray Kalkan
Recep Tayyip Erdoğan Üniversitesi, Türkiye
İbrahim Aydın
Recep Tayyip Erdoğan Üniversitesi, Türkiye
Prof. Dr. Aynur KIRBAŞ Recep Tayyip Erdoğan Üniversitesi, Türkiye
Arif Yılmaz
Recep Tayyip Erdogan University, Türkiye
Süleyman Yüce
Recep Tayyip Erdogan University, Türkiye
Ahmet Fikret Yücel
Recep Tayyip Erdoğan Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Biomed Research International
Dergi ISSN 2314-6133 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 01-2014
Cilt No 2014
Sayı 1
Sayfalar 1 / 8
DOI Numarası 10.1155/2014/907915
Makale Linki http://www.hindawi.com/journals/bmri/2014/907915/
Özet
The aim of this study was to investigate the possible protective effects of adalimumab (ADA) on cell damage in rat liver tissue during ischemia/reperfusion (I/R) injury of infrarenal abdominal aorta. Thirty male Wistar-albino rats were divided into three groups: control, I/R, and I/R+ADA, each group containing 10 animals. Laparotomy without I/R injury was performed in the control group animals. Laparotomy in the I/R group was followed by two hours of infrarenal abdominal aortic cross ligation and then two hours of reperfusion. ADA (50 mg/kg) was administered intraperitoneally as a single dose, to the I/R+ADA group, five days before I/R. The tumor necrosis factor-alpha (TNF-alpha) (pg/mg protein) and nitric oxide (NO) (mu mol/g protein) levels in the I/R group (430.8 +/- 70.1, 8.0 +/- 1.1, resp.) were significantly higher than those in the I/R+ADA group (338.0 +/- 71.6, P = 0.006; 6.3 +/- 1.2, P = 0.008) and the control group (345.5 +/- 53.3, P = 0.008; 6.5 +/- 1.5, P = 0.010, resp.). I/R causes severe histopathological injury to the liver tissue, but ADA leads to much less histopathological changes. ADA treatment significantly decreased the severity of liver I/R injury. ADA pretreatment may have protective effects on experimental liver injury.
Anahtar Kelimeler